CKD: LAI Recommendations

Written By: user Dr. Sonika Puri
Published On: 18 Aug, 2022 11:35 AM | Updated On: 23 Nov, 2024 7:35 PM

CKD: LAI Recommendations

A combination of statins/statin plus ezetimibe is recommended

in all adults over the age of 40 years with chronic

kidney disease (CKD) stage 3 or higher.

In adults between the ages of 18 and 39 with CKD should

be treated with statins if they have one of the following:

Known coronary artery disease (CAD), stroke or

peripheral vascular disease

Diabetes mellitus

Life-time risk of atherosclerotic cardiovascular disease (ASCVD) >30%.

Patients who are already receiving lipid-lowering therapy at the time of starting

dialysis should continue to receive these agents.

user
Dr. Sonika Puri

Dr. Sonika Puri is a Assistant Professor in the Division of Nephrology at Rutgers-Robert Wood Johnson Medical School in New Brunswick and was Assistant Professor at M.S. Ramaiah Medical College in Bangalore, India. She is a member of the American Society of Nephrology; Lipid Association of India; Association of Vascular Access and Interventional Renal Physicians; and Fellow of American Society of Nephrology. She is fluent in Hindi and Punjabi. She has published extensively on postpartum acute kidney injury, central venous stenosis, and antibody mediated rejection. She has also co-authored guidelines on management of Dyslipidemia in Indian patients with chronic kidney disease. She is fluent in Hindi and Punjabi.

 More FAQs by Dr. Sonika Puri
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks